TheraRadar
← Back
Data updated: Mar 29, 2026

CIS

RespiratoryOncologyOphthalmology
Pharma

CIS is a pharmaceutical company focused on Respiratory, Oncology, Ophthalmology.

1976
Since
1
Drugs
-
Trials
1
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

SODIUM IODIDE I 131 2025-06-12
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Respiratory 58%
0 drugs Phase 3: 16 Phase 2: 14 Phase 1: 27
Oncology 22%
0 drugs Phase 3: 2 Phase 2: 3 Phase 1: 30
Ophthalmology 8%
0 drugs Phase 3: 2 Phase 2: 4 Phase 1: 1
Neurology 6%
0 drugs Phase 3: 2 Phase 2: 2 Phase 1: 1
Metabolic 5%
0 drugs Phase 2: 5 Phase 1: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Roche big-pharma
Oncology, Neurology, Ophthalmology, Respiratory
Novartis big-pharma
Oncology, Ophthalmology, Respiratory
AbbVie big-pharma
Oncology, Neurology, Ophthalmology
GSK big-pharma
Respiratory, Oncology, Neurology
Sanofi big-pharma
Metabolic, Oncology, Respiratory